Skip to main content
. 2008 Feb;4(1):245–259. doi: 10.2147/tcrm.s1928

Figure 2.

Figure 2

Comparison of adverse events (AE) encountered with long term therapeutic use of herbal cannabis in the Netherlands (Janse et al 2004; Gorter et al 2005) and Canada (Lynch et al 2006), vs that observed in safety-extension (SAFEX) studies of Sativex oromucosal spray (Russo 2006; Wade et al 2006).